Inherited changes in the tumor suppressor genes BRCA1 and BRCA2, raise lifetime risk substantially. For ovarian cancer, the ...

October 7, 2010 — The assumption that ovarian cancer survival would improve with early treatment of relapse (after a rise in CA125 concentration but prior to clinical or symptomatic disease) has been ...

Nov. 7, 2024 -- Ovarian cancer is often called the “silent killer” for a reason: its early symptoms can be subtle, making it easy to mistake for other conditions. But being proactive about our health ...

Ovarian cancer, often termed a 'silent killer,' is frequently diagnosed late due to subtle, easily dismissed early symptoms ...

NEW YORK (Reuters Health) - Women with ovarian cancer who are overweight or obese fare worse than normal-weight patients, a new study shows. Sign up here. "This is just one more reason why women ...

Cancer is a serious illness that affects millions of people each year, when cells in their body grow out of control. There are many different types, but the most common include breast cancer, lung ...

Elahere is a type of targeted therapy called an antibody-drug conjugate. This antibody-drug conjugate is made up of an antibody that is attached to a cancer medicine. Elahere is used to treat a type ...